Clinical significance of patient-reported questionnaire data: Another step toward consensus

Journal of Clinical Epidemiology

Volumn 58, Issue 12, 2005, Pages 1217-1219

  Sloan, Jeff A ^a   Cella, David ^b   Hays, Ron D ^c,d  

^a MAYO CLINIC   (United States)

^b EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CULTURE; CONSENSUS; EDITORIAL; HUMAN; MEDICAL LITERATURE; MEDICAL PRACTICE; ONCOLOGY; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RESEARCH;

CONSENSUS; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; HEALTH SURVEYS; HUMANS; NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 27744532631     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2005.07.009     Document Type: Editorial

References (28)

1. K.J. Yost, D. Cella, A. Chawla, E. Holmgren, D.T. Eton, J.Z. Ayanian, and D.W. West Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches J Clin Epidemiol 58 2005 1241 1251 (this issue)
2. E. Lydick, and R.S. Epstein Interpretation of quality of life changes Qual Life Res 2 1993 221 226
3. G.H. Guyatt, D. Osoba, A.W. Wu, K.W. Wyrwich, and G.R. Norman Clinical Significance Consensus Meeting Group. Methods to explain the clinical significance of health status measures Mayo Clin Proc 2002 371 383
4. D.K. Moser Psychosocial factors and their association with clinical outcomes in patients with heart failure: why clinicians do not seem to care Eur J Cardiovasc Nurs 1 2002 183 188
5. M.L. Unruh, S.D. Weisbord, and P.L. Kimmel Health-related quality of life in nephrology research and clinical practice [Review] Semin Dial 18 2005 82 90
6. E.H. Morreim The impossibility and necessity of quality of life research Bioethics 6 1992 218 232
7. D. Osoba, A. Bezjak, M. Brundage, B. Zee, D. Tu, and J. Pater Quality of Life Committee of the NCIC CTG. Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of the National Cancer Institute of Canada Clinical Trials Group Eur J Cancer 41 2005 280 287
8. J.Z. Ayanian, E.A. Chrischilles, R.B. Wallace, R.H. Fletcher, M.N. Fouad, C.I. Kiefe, D.P. Harrington, J.C. Weeks, K.L. Kahn, J.L. Malin, J. Lipscomb, A.L. Potosky, D.T. Provenzale, R.S. Sandler, M. van Ryn, and D.W. West Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium [Comments and Controversies] J Clin Oncol 22 2004 2992 2996
9. R.D. Hays, M. Brodsky, M.F. Johnston, K.L. Spritzer, and K. Hui Evaluating the statistical significance of health-related quality of life change in individual patients Eval Health Prof 28 2005 160 171
10. R. Jaeschke, J. Singer, and G.H. Guyatt Measurements of health status: ascertaining the minimal clinically important difference Control Clin Trials 10 1989 407 415
11. D.A. Osoba Taxonomy of the uses of health-related quality-of-life instruments in cancer care and the clinical meaningfulness of the results Med Care 40 Suppl 2002 III-31 III-38
12. M.H. Frost, and J.A. Sloan Quality of life measurements: a soft outcome - or is it? Am J Manag Care 8 2002 S574 S579
13. B. Movsas, and C. Scott Quality-of-life trials in lung cancer: past achievements and future challenges Hematol Oncol Clin N Am 18 2004 161 186
14. A. Bottomley, V. Vanvoorden, H. Flechtner, and P. Therasse EORTC Quality of Life Group; EORTC Data Center. The challenges and achievements involved in implementing quality of life research in cancer clinical trials Eur J Cancer 39 2003 275 285
15. R.B. Giesler, and S.D. Williams Opportunities and challenges: assessing quality of life in clinical trials J Natl Cancer Inst 90 1998 1498 1499
16. R.M. Baars, S.M. van der Pal, H.M. Koopman, and J.M. Wit Clinicians' perspective on quality of life assessment in paediatric clinical practice Acta Paediatr 93 2004 1356 1362
17. M. Welsh Parkinson's disease and quality of life: issues and challenges beyond motor symptoms Neurol Clin 22 3 Suppl 2004 S141 S148
18. K.W. Wyrwich Minimal important difference thresholds and the standard error of measurement: is there a connection? J Biopharmaceut Stat 14 2004 97 110
19. J. Sloan, T. Symonds, D. Vargas-Chanes, and B. Fridley Practical guidelines for assessing the clinical significance of health-related quality of life changes within clinical trials Drug Inf J 37 2003 23 31
20. P. Tugwell, M. Boers, P.M. Brooks, L. Simon, and C.V. Strand OMERACT 5: International Consensus Conference on Outcome Measures in Rheumatology: Minimal Clinically Important Difference Module J Rheumatol 28 2001 395 460
21. J.A. Sloan Assessing the minimally clinically significant difference: scientific considerations, challenges and solutions J Chronic Obstructive Pulm Dis 2 2005 57 62
22. Tugwell P, Guyatt G. Generating measurements, especially for quality of life. In: Haynes RB, Sackett DL, Guyatt GH, Tugwell P, editors. Clinical epidemiology: how to do clinical practice research. 3rd ed. Philadelphia: Lippincott Williams & Wilkins [forthcoming].
23. G.R. Norman, J.A. Sloan, and K.W. Wyrwich Interpretation of changes in health-related quality of life: the remarkable universality of a half a standard deviation Med Care 41 2003 582 592
24. J.A. Sloan, D. Vargas-Chanes, C.C. Kamath, D.J. Sargent, P.J. Novotny, P. Atherton, C. Allmer, B.L. Fridley, M.H. Frost, and C.L. Loprinzi Detecting worms, ducks and elephants: a simple approach for defining clinically relevant effects in quality-of-life measures J Cancer Integr Med 1 2003 41 47
25. R.D. Hays, and J.M. Woolley The concept of clinically meaningful difference in health-related quality-of-life research: how meaningful is it? Pharmacoeconomics 18 2000 419 423
26. G.R. Norman, J.A. Sloan, and K.W. Wyrwich The truly remarkable universality of half a standard deviation: confirmation through another look Expert Rev Pharmacoecon Outcomes Res 4 2004 515 519
27. D.F. Cella, M.J. Zagari, C. Vandoros, D.D. Gagnon, H.J. Huntz, and J.W.R. Nortier Epoetin alfa treatment results in clinically significant improvements in quality of life (QOL) in anemic cancer patients when referenced to the general population J Clin Oncol 21 2003 366 373
28. S.S. Farivar, H. Kiu, and R.D. Hays Another look at the half standard deviation estimate of the minimally important difference in health-related quality of life scores Expert Rev Pharmacoecon Outcomes Res 4 2004 521 529